Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Nov 18, 2026
Reporting period
Not applicable
Filed with the SEC
Nov 20, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001493152-26-053343
Filed / recorded
Nov 20, 2026, 11:45 AM UTC
Added to OQRO
Nov 20, 2026, 11:50 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
RenovoRx, Inc.
Issuer CIK
1574094
Ticker
RNXT
Reporting person
Richard Stark
Relationship
Director
Security
Stock Option (right to buy)
Table
Derivative (Table II)
Transaction date
Nov 18, 2026
Transaction code
A
Shares / units
128,824
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
128,824
Ownership form
Direct
Amendment
No
Footnotes from the filing
The option vests and becomes exercisable in 36 equal monthly installments on the 18th day of each month beginning December 18, 2026, subject to the Reporting Person's continued service, and vests in full upon a change in control of the Issuer.
Largest insider buy since 2022Traded Nov 16 · filed 1 day later
Renovorx's Executive Chairman and CMO paid $46K out of pocket for Renovorx shares. It was the first purchase in 17 months. Shares held went up 6% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.